InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,985.38
(
0.02%
)
US TECH 100
20,485.20
(
-0.15%
)
Dow Jones
43,958.19
(
0.11%
)
Brent Oil
71.87
(
0.00%
)
Bitcoin
90,338.08
(
-0.25%
)
Post# of 473987
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

nidan7500

Send PM Follow Ignore
Followers 58
Posts 10388
Boards Moderated 1
Alias Born 09/21/2016

nidan7500

Re: MayoMobile post# 395259

Thursday, 12/29/2022 3:06:36 PM

Thursday, December 29, 2022 3:06:36 PM

Post# of 473987
MatoMo

My opinion regarding the outlook for Blarcamesine at the FDA:

I do not believe the review process will be slower (I don’t believe it will be faster either). However, with the new scrutiny on the FDA to provide drugs that are safe and efficacious, it seems reasonable to me that Blarcamesine very well may have just slid into the top contender over Lecanemab.



Totally agree w/this point. Injection vs pill . Fewer AE worries based on history. A strong AVXL TLR report puts the FDA in a good position to support AXVL approval. They have a WIN-WIN.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM

Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM

Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM

SANUWAVE Announces Record Quarterly Revenues:  Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM

DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM

SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM

Start posting your company's news
Only $200 per official company press release!